Top articles 2011
1 = Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria Polman, CH.; Reingold, SC; Banwell, B; et al.
ANNALS OF NEUROLOGY Volume: 69 Issue: 2 Pages: 292-302 Published: FEB 2011 Times Cited: 367 (from Web of Science)
A comment to this top article can be found here.
2 = Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS
Zivadinov, R; Marr, K; Cutter, G; et al.
NEUROLOGY Volume: 77 Issue: 2 Pages: 138-144 Published: JUL 2011
Times Cited: 77 (from Web of Science)
3 = Sun exposure and vitamin D are independent risk factors for CNS demyelination Lucas, RM; Ponsonby, A-L; Dear, K; et al.
NEUROLOGY Volume: 76 Issue: 6 Pages: 540-548 Published: FEB 8 2011
Times Cited: 68 (from Web of Science)
4 = Responsive cortical stimulation for the treatment of medically intractable partial epilepsy
Morrell, MJ; RNS Syst Epilepsy Study Grp
NEUROLOGY Volume: 77 Issue: 13 Pages: 1295-1304 Published: SEP 2011
Times Cited: 54 (from Web of Science)
5 ˅ Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy
French, JA.; Abou-Khalil, BW; Leroy, RF; et al. RESTORE 1 Study 301 Investigators NEUROLOGY Volume: 76 Issue: 18 Pages: 1555-1563 Published: MAY 2011
Times Cited: 54 (from Web of Science)
6 ˅ Screening for tumours in paraneoplastic syndromes: report of an EFNS task force Titulaer, MJ; Soffietti, R; Dalmau, J; et al.
EUROPEAN JOURNAL OF NEUROLOGY Volume: 18 Issue: 1 Pages: 19-E3 Published: JAN 2011
Times Cited: 51 (from Web of Science) A comment to this top article can be found here.
7 ˅ Guidelines in practice: treatment of painful diabetic neuropathy
Bril, V.; England, J.; Franklin, G. M.; et al.
NEUROLOGY Volume: 76 Issue: 20 Pages: 1758-1765 Published: MAY 2011
Times Cited: 50 (from Web of Science)
8 ˅ Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease
Li, J; Wang, YJ; Zhang, M; et al. Chongqing Ageing Study Grp
NEUROLOGY Volume: 76 Issue: 17 Pages: 1485-1491 Published: APR 2011
Times Cited: 47 (from Web of Science)
8 = Default mode network connectivity in stable vs progressive mild cognitive impairment
Petrella, JR; Sheldon, FC; Prince, SE; et al.
NEUROLOGY.; Volume 76 Issue:6: Pages: 511-7. FEB 8 2011
Times Cited: 45 (from Web of Science)
9 ˅ Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Cortese, I; Chaudhry, V; So, YT; et al.
NEUROLOGY Volume: 76 Issue: 3 Pages: 294-300 Published: JAN 18 2011
Times Cited: 45 (from Web of Science)
10 = Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis
O’Connor, PW; Goodman, A; Kappos, L; et al.
NEUROLOGY Volume: 76 Issue: 22 Pages: 1858-1865 Published: MAY 2011
Times Cited: 43 (from Web of Science)
Top Articles 2010
1 = HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.
Heaton, RK; Clifford, DB; Franklin, DR; et al. CHARTER Grp
NEUROLOGY Volume: 75 Issue: 23 Pages: 2087-2096 Published: DEC 7 2010
Times Cited: 204 (from Web of Science)
2 = Alzheimer’s Disease Neuroimaging Initiative (ADNI): clinical characterization Petersen, RC; Aisen, PS; Beckett, LA; et al.
NEUROLOGY Volume: 74 Issue: 3 Pages: 201-209 Published: JAN 19 2010
Times Cited: 122 (from Web of Science)
3 = Prognostication after cardiac arrest and hypothermia: a prospective study Rossetti, AO; Oddo, M; Logroscino, G; et al.
ANNALS OF NEUROLOGY Volume: 67 Issue: 3 Pages: 301-307 Published: MAR 2010 Times Cited: 121 (from Web of Science)
A comment to this top article can be found here.
4 = Comparing predictors of conversion and decline in mild cognitive impairment Landau, S. M.; Harvey, D.; Madison, C. M.; et al. Alzheimer’s Dis Neuroimaging Inititiative
NEUROLOGY Volume: 75 Issue: 3 Pages: 230-238 Published: JUL 20 2010 Times Cited: 109 (from Web of Science)
5 = Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe
Feldman, HH; Doody, RS; Kivipelto, M; et al. LEADe Investigators NEUROLOGY Volume: 74 Issue: 12 Pages: 956-964 Published: MAR 23 2010
Times Cited: 100 (from Web of Science)
6 ˄ Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis Aarsland, D; Bronnick, K; Williams-Gray, C; et al.
NEUROLOGY Volume: 75 Issue: 12 Pages: 1062-1069 Published: SEP 21 2010
Times Cited: 96 (from Web of Science)
7 v A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis Burton, JM; Kimball, S; Vieth, R; et al.
NEUROLOGY Volume: 74 Issue: 23 Pages: 1852-1859 Published: JUN 8 2010
Times Cited: 94 (from Web of Science)
8 = IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
Houillier, C; Wang, X; Kaloshi, G; et al.
NEUROLOGY Volume: 75 Issue: 17 Pages: 1560-1566 Published: OCT 26 2010 Times Cited: 79 (from Web of Science)
9 ˄ REM sleep behaviour disorder preceding other aspects of synucleinopathies by up to half a century.
Claassen, DO; Josephs, KA; Ahlskog, JE; et al.
NEUROLOGY Volume: 75 Issue: 6 Pages: 494-499 Published: AUG 10 2010
Time Cited: 80 (from Web of Science)
9 v A prospective diffusion tensor imaging study in mild traumatic brain injury
Mayer, AR; Ling, J; Mannell, MV; et al.
NEUROLOGY Volume: 74 Issue: 8 Pages: 643-650 Published: FEB 23 2010
Times Cited: 80 (from Web of Science)
10 v Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology
Wijdicks, EFM; Varelas, PN; Gronseth, GS; et al.
NEUROLOGY Volume: 74 Issue: 23 Pages: 1911-1918 Published: JUN 8 2010
Times Cited: 77 (from Web of Science)
